Investment
Features
FeesSafety
Academy
More
Pluang+

Powerfleet to discuss AIoT platform and strategy at Barrington Research Conference on Sept 22

Market News
18 Sep 2026
PRNewsWire
View Source
Neutral
Powerfleet to discuss AIoT platform and strategy at Barrington Research Conference on Sept 22

Powerfleet, a global leader in AIoT software for mobile assets, will present at the 19th Annual Barrington Research Virtual Fall Investment Conference on September 22. Management plans to discuss the company's Unity AIoT platform, recent financial performance, and strategic plans to drive long-term shareholder value. This event offers investors insight into Powerfleet's business model and growth prospects. Powerfleet operates globally with listings on Nasdaq and Johannesburg Stock Exchange.

Powerfleet's upcoming presentation at the 19th Annual Barrington Research Virtual Fall Investment Conference provides context for market watchers. For readers following the Technology sector, here is Pluang's market snapshot as of Sep 18, 2026 21:31 WIB: Among 150 priced US Technology stocks, 36 rose and 113 fell today. Notable movers include BTDR (Bitdeer Technologies Group) at USD 12.03 with a 1-day change of +6.98% and a typical hold time on Pluang of 15 days, NET (Cloudflare Inc) at USD 315.28 down 5.64% with a 60-day hold time, and QBTS (D Wave Quantum Inc) at USD 16.72 down 5.48% with a 29-day hold time.

More News

Duke Energy's stock shows 8.26% upside with strong earnings forecast and mixed institutional interest.

Duke Energy's stock shows 8.26% upside with strong earnings forecast and mixed institutional interest.

Duke Energy Corporation's stock is projected to rise about 8.26% to a price target of $127, down slightly from $133, reflecting confidence despite a recent price dip. The company expects a 4.42% increase in earnings per share to $1.89 and a 3.86% ris...

Analyst Insights
Bullish
1 hour ago
Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals halted new patient enrollment in its psychiatry clinical trials for the drug azetukalner after reports of neuropsychiatric side effects. This pause led to a sharp 27.6% drop in its stock price, marking its worst day since 2017. ...

Market News
Bearish
2 hours ago
Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma reported an EPS of -$0.24, beating analyst estimates of -$0.29, and revenue of $6.5 million, slightly above expectations. The company secured a strategic partnership with Sobi for its drug lacutamab, receiving a $75 million upfront paym...

Company Fundamentals
Bullish
3 hours ago
Paychex to report Q1 2027 earnings with expected EPS of $1.32 and $1.63B revenue on Sept 23

Paychex to report Q1 2027 earnings with expected EPS of $1.32 and $1.63B revenue on Sept 23

Paychex, a provider of human capital management solutions, will release its Q1 fiscal 2027 earnings on September 23, 2026. Analysts expect earnings per share (EPS) of $1.32, up from $1.22 last year, and revenue of about $1.63 billion, higher than las...

Company Fundamentals
Bullish
4 hours ago
Semiconductor ETFs remain strong buys amid AI-driven demand and investment growth.

Semiconductor ETFs remain strong buys amid AI-driven demand and investment growth.

iShares Semiconductor ETF and VanEck Semiconductor ETF are recommended as strong buys due to robust capital investment driven by AI infrastructure and sector demand outpacing the broader market. The AI buildout is attracting unprecedented capital int...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App